Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2022 Feb 8;14(2):352. doi: 10.3390/v14020352

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2022 by the authors.

Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).

PMC Copyright notice

Kaplan–Meier survival curve analysis of patients with CMV GI diseases. (A) Patients with different infected locations had no statistical difference in in-hospital mortality rates (log-rank p = 0.806). (B) Patients with immunocompromised status had significantly worse survival outcomes than those with immunocompetent status (log-rank p = 0.017). (C) Patients receiving Combo therapy had significantly better survival outcomes than others (log-rank p = 0.002). (D) Patients with different immune status and treatment courses had significantly different survival outcomes (log-rank p = 0.001). CMV, cytomegalovirus; CO, colon; Combo, combination of intravenous and oral antiviral therapy; ES, esophagus; GI, gastrointestinal; SI, small intestine; ST, stomach.